Ichnos Investigational Site 322

Bielefeld, North Rhine-Westphalia 33647

0 studies enrolling now · 1 studies all time

What they study most

Moderate to Severe Atopic Dermatitis

Studies at this site

• Phase 2b Study to Evaluate the Efficacy and Safety of ISB 830 in Adults With Moderate to Severe Atopic Dermatitis — Completed